Chemoinformaics analysis of Azelaic (Nonanedioic) Acid
| Molecular Weight | 337.413 | nRot | 14 |
| Heavy Atom Molecular Weight | 306.165 | nRig | 2 |
| Exact Molecular Weight | 337.21 | nRing | 0 |
| Solubility: LogS | -1.49 | nHRing | 0 |
| Solubility: LogP | 1.216 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 31 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 52.4346 |
| nHD | 5 | BPOL | 34.5454 |
| QED | 0.57 |
| Synth | 1.641 |
| Natural Product Likeliness | 0.433 |
| NR-PPAR-gamma | 0.924 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.068 |
| CACO-2 | -5.745 |
| MDCK | 0.0000872 |
| BBB | 0.043 |
| PPB | 0.838855 |
| VDSS | 0.26 |
| FU | 0.152036 |
| CYP1A2-inh | 0.017 |
| CYP1A2-sub | 0.073 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.009 |
| CYP2c9-sub | 0.972 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.106 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.006 |
| CL | 1.727 |
| T12 | 0.85 |
| hERG | 0.005 |
| Ames | 0.008 |
| ROA | 0.008 |
| SkinSen | 0.13 |
| Carcinogencity | 0.137 |
| EI | 0.983 |
| Respiratory | 0.04 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.646538 |